Ignite Creation Date:
2024-05-05 @ 12:02 PM
Last Modification Date:
2024-10-26 @ 9:19 AM
Study NCT ID:
NCT00228358
Status:
COMPLETED
Last Update Posted:
2014-11-11
First Post:
2005-09-13
Brief Title:
Cyclophosphamide or Denileukin Diftitox Followed By Expanding a Patients Own T Cells in the Laboratory in Treating Patients With HER-2Neu Overexpressing Metastatic Breast Cancer Ovarian Cancer or Non-Small Cell Lung Cancer Previously Treated With HER-2Neu Vaccine
Sponsor:
University of Washington
Organization:
University of Washington
Conditions & Keywords Data
Conditions:
| Name |
|---|
| HER2-positive Breast Cancer |
| Recurrent Breast Cancer |
| Recurrent Non-small Cell Lung Cancer |
| Recurrent Ovarian Epithelial Cancer |
| Recurrent Ovarian Germ Cell Tumor |
| Stage IV Breast Cancer |
| Stage IV Non-small Cell Lung Cancer |
| Stage IV Ovarian Epithelial Cancer |
| Stage IV Ovarian Germ Cell Tumor |
Keywords: